# Eli Lilly and Company (LLY) — Q3-2009 Earnings Results

**Report date:** 2009-10-21 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2009

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down 4.5%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.86 | N/A | -15.52% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about the recent performance and highlighted the need for strategic adjustments. They did not provide specific guidance for future quarters.

**Key quotes:**

> Management acknowledged the challenges faced during the quarter.

> They emphasized a focus on long-term strategies despite the current results.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report indicates a disappointing quarter with a notable EPS miss, which contributed to a 4.5% decline in stock price. Investors may be concerned about the company's ability to meet expectations moving forward, especially given the lack of guidance. The management's defensive tone suggests they are aware of the challenges ahead and are focusing on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2009_